10.89
price up icon0.18%   0.02
 
loading

Finanzdaten der Evolus Inc-Aktie (EOLS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
2.73%
59.33
61.00 50.02 49.35 41.72
Cost Of Revenue
6.24%
18.07
19.27 15.43 14.71 12.15
Gross Profit
1.11%
41.27
41.73 34.59 34.63 29.57
Operating Expenses
0.35%
50.19
50.36 48.03 49.75 41.62
Interest Income/Expense
15.39%
4.702
4.075 3.786 3.182 2.789
Benefits Costs and Expenses
0.45%
72.39
72.72 66.92 67.46 56.49
Costs And Expenses
1.98%
68.25
69.63 63.46 64.46 53.76
Operating Income/Loss
3.32%
-8.922
-8.635 -13.44 -15.12 -12.04
Income/Loss From Continuing Operations Before Tax
11.40%
-13.06
-11.72 -16.90 -18.12 -14.77
Income Tax Expense/Benefit, Deferred
0.00%
0.005
0.005 - - -
Income Tax Expense/Benefit
55.66%
0.047
0.106 0.024 0.023 0.023
Income/Loss From Continuing Operations After Tax
10.80%
-13.11
-11.83 -16.92 -18.14 -14.79
Net Income/Loss
10.80%
-13.11
-11.83 -16.92 -18.14 -14.79
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
53,164%
58.80
0.1104 57.02 56.92 56.48
Diluted Average Shares
53,164%
58.80
0.1104 57.02 56.92 56.48
Basic Earnings Per Share
10.00%
-0.22
-0.20 -0.30 -0.32 -0.26
Diluted Earnings Per Share
10.00%
-0.22
-0.20 -0.30 -0.32 -0.26
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$11.63
price down icon 1.61%
$89.28
price down icon 2.89%
$83.45
price down icon 0.82%
drug_manufacturers_specialty_generic RDY
$15.37
price up icon 1.65%
$135.42
price up icon 0.34%
$12.52
price up icon 3.22%
Kapitalisierung:     |  Volumen (24h):